Lv736
4730 积分 2023-04-18 加入
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
10天前
已完结
Clinical pharmacokinetic characteristics of Jaktinib in subjects with hepatic impairment in a phase I trial
12天前
已完结
Novel Janus-kinase (JAK) Inhibitors in Myelofibrosis
12天前
已完结
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
11个月前
已完结
UKPDS and the Legacy Effect
11个月前
已完结
Diet Quality and Body Mass Index Over 20 Years in the Multiethnic Cohort
1年前
已完结
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
1年前
已完结
Association Between Time in Range and Postprandial Glucose Contribution Rate in Non-Insulin-Treated Type 2 Diabetes Patients: Inverse Correlation of Time in Range with Postprandial Glucose Contribution Rate
1年前
已完结
Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database
1年前
已完结
皖公网安备34019202002308
